NextPlat (NXPL) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
16 Mar, 2026Business overview
Operates globally in healthcare and technology, providing e-commerce and retail solutions for consumer products and services.
Focuses on high-growth sectors such as technology, healthcare, and consumer wellness, leveraging proprietary software and enterprise platforms.
Maintains a diversified portfolio, selling thousands of products to consumers, governments, and corporations worldwide, both online and through pharmacy operations.
Offers connectivity, communication, IoT, and pharmacy services, serving over 190 countries and a wide range of clients including governments and humanitarian organizations.
Listed on Nasdaq under NXPL, with 26.9 million shares outstanding as of March 2026.
Financial performance
Reported $65.5 million in consolidated revenues for the year ended December 31, 2024.
Q3 2025 revenue was $13.8 million, with ongoing cost reduction and efficiency improvements.
Cash position of $13.9 million as of September 30, 2025, and a market cap of $14.0 million as of March 2026.
Net loss for Q3 2025 was $2.2 million, with total assets of $30.0 million and stockholders’ equity of $21.5 million.
No long-term debt, supporting a clean capital structure.
Strategic initiatives and growth
Expanding into China’s online consumer market via Alibaba’s Tmall Global, enabling rapid access to a large customer base.
Launched OPKO and Florida Sunshine flagship stores in China, Europe, and North America, targeting health and wellness sectors.
Entered new markets in Latin America through e-commerce expansion on Mercado Libre.
Focused on high-margin recurring revenue streams, especially in healthcare and 340B contract services.
Strategic investments, acquisitions, and partnerships in healthcare, consumer lifestyle, and pet products.
Latest events from NextPlat
- Shareholders will vote on a reverse stock split to maintain Nasdaq listing and improve liquidity.NXPL
Proxy Filing16 Mar 2026 - Shareholders will vote on a reverse stock split to maintain Nasdaq listing and enhance liquidity.NXPL
Proxy Filing3 Mar 2026 - 2024 revenue hit $65.5M, up 73%, but net loss widened on higher costs and investments.NXPL
Q4 202426 Dec 2025 - Registering up to $300M in securities to fund growth amid ongoing losses and market risks.NXPL
Registration Filing17 Dec 2025 - Proxy covers director elections, auditor ratification, and executive pay, with strong governance.NXPL
Proxy Filing2 Dec 2025 - Proxy supplement clarifies XBRL tagging, equity award timing, and executive pay disclosures.NXPL
Proxy Filing2 Dec 2025 - Proxy statement covers annual meeting proposals, director elections, and governance.NXPL
Proxy Filing2 Dec 2025 - Board vacancy to be filled post-meeting after nominee's unexpected passing.NXPL
Proxy Filing2 Dec 2025 - Revenue fell 17% to $14.5M as cost controls and e-commerce gains offset tariff and healthcare risks.NXPL
Q1 202525 Nov 2025